ACR-ASNR Practice Parameter for Brain PET/CT Imaging Dementia

Kirk A. Frey, Martin A. Lodge, Carolyn Cidis Meltzer, Patrick J. Peller, Terence Z. Wong, Christopher P. Hess, Jeffrey R. Petrella, Haris I. Sair, Rathan M. Subramaniam

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

This practice parameter is for both FDG and amyloid brain PET or PET/computed tomography (CT) for patients with cognitive decline, and has been developed collaboratively by the American College of Radiology (ACR) and the American Society for Neuroradiology (ASNR). It is estimated that the number of people with dementia, 36.5 million worldwide in 2010, will increase to 65.7 million in 2030 and to 115 million in 2050. Four primary neurodegenerative etiologies of dementia have been defined: Alzheimer disease (AD), vascular dementia, frontotemporal dementia (FTD), and dementia with Lewy bodies (DLB). Alzheimer disease is the most common form of dementia, accounting for approximately 60%-80% of all cases. Indications for FDG and amyloid brain PET and qualifications for personnel are discussed in this practice parameter.

Original languageEnglish (US)
Pages (from-to)118-125
Number of pages8
JournalClinical Nuclear Medicine
Volume41
Issue number2
DOIs
StatePublished - Feb 1 2016

Fingerprint

Radiology
Dementia
Tomography
Amyloid
Alzheimer Disease
Brain
Lewy Body Disease
Frontotemporal Dementia
Vascular Dementia

Keywords

  • Alzheimer disease
  • amyloid PET
  • Brain imaging
  • Brain PET/CT
  • dementia
  • frontotemporal dementia
  • FTD
  • memory
  • PET/CT
  • vascular dementia

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging

Cite this

Frey, K. A., Lodge, M. A., Meltzer, C. C., Peller, P. J., Wong, T. Z., Hess, C. P., ... Subramaniam, R. M. (2016). ACR-ASNR Practice Parameter for Brain PET/CT Imaging Dementia. Clinical Nuclear Medicine, 41(2), 118-125. https://doi.org/10.1097/RLU.0000000000001037

ACR-ASNR Practice Parameter for Brain PET/CT Imaging Dementia. / Frey, Kirk A.; Lodge, Martin A.; Meltzer, Carolyn Cidis; Peller, Patrick J.; Wong, Terence Z.; Hess, Christopher P.; Petrella, Jeffrey R.; Sair, Haris I.; Subramaniam, Rathan M.

In: Clinical Nuclear Medicine, Vol. 41, No. 2, 01.02.2016, p. 118-125.

Research output: Contribution to journalArticle

Frey, KA, Lodge, MA, Meltzer, CC, Peller, PJ, Wong, TZ, Hess, CP, Petrella, JR, Sair, HI & Subramaniam, RM 2016, 'ACR-ASNR Practice Parameter for Brain PET/CT Imaging Dementia', Clinical Nuclear Medicine, vol. 41, no. 2, pp. 118-125. https://doi.org/10.1097/RLU.0000000000001037
Frey KA, Lodge MA, Meltzer CC, Peller PJ, Wong TZ, Hess CP et al. ACR-ASNR Practice Parameter for Brain PET/CT Imaging Dementia. Clinical Nuclear Medicine. 2016 Feb 1;41(2):118-125. https://doi.org/10.1097/RLU.0000000000001037
Frey, Kirk A. ; Lodge, Martin A. ; Meltzer, Carolyn Cidis ; Peller, Patrick J. ; Wong, Terence Z. ; Hess, Christopher P. ; Petrella, Jeffrey R. ; Sair, Haris I. ; Subramaniam, Rathan M. / ACR-ASNR Practice Parameter for Brain PET/CT Imaging Dementia. In: Clinical Nuclear Medicine. 2016 ; Vol. 41, No. 2. pp. 118-125.
@article{17788d8981a642f784b5f4a34c98797e,
title = "ACR-ASNR Practice Parameter for Brain PET/CT Imaging Dementia",
abstract = "This practice parameter is for both FDG and amyloid brain PET or PET/computed tomography (CT) for patients with cognitive decline, and has been developed collaboratively by the American College of Radiology (ACR) and the American Society for Neuroradiology (ASNR). It is estimated that the number of people with dementia, 36.5 million worldwide in 2010, will increase to 65.7 million in 2030 and to 115 million in 2050. Four primary neurodegenerative etiologies of dementia have been defined: Alzheimer disease (AD), vascular dementia, frontotemporal dementia (FTD), and dementia with Lewy bodies (DLB). Alzheimer disease is the most common form of dementia, accounting for approximately 60{\%}-80{\%} of all cases. Indications for FDG and amyloid brain PET and qualifications for personnel are discussed in this practice parameter.",
keywords = "Alzheimer disease, amyloid PET, Brain imaging, Brain PET/CT, dementia, frontotemporal dementia, FTD, memory, PET/CT, vascular dementia",
author = "Frey, {Kirk A.} and Lodge, {Martin A.} and Meltzer, {Carolyn Cidis} and Peller, {Patrick J.} and Wong, {Terence Z.} and Hess, {Christopher P.} and Petrella, {Jeffrey R.} and Sair, {Haris I.} and Subramaniam, {Rathan M.}",
year = "2016",
month = "2",
day = "1",
doi = "10.1097/RLU.0000000000001037",
language = "English (US)",
volume = "41",
pages = "118--125",
journal = "Clinical Nuclear Medicine",
issn = "0363-9762",
publisher = "Lippincott Williams and Wilkins",
number = "2",

}

TY - JOUR

T1 - ACR-ASNR Practice Parameter for Brain PET/CT Imaging Dementia

AU - Frey, Kirk A.

AU - Lodge, Martin A.

AU - Meltzer, Carolyn Cidis

AU - Peller, Patrick J.

AU - Wong, Terence Z.

AU - Hess, Christopher P.

AU - Petrella, Jeffrey R.

AU - Sair, Haris I.

AU - Subramaniam, Rathan M.

PY - 2016/2/1

Y1 - 2016/2/1

N2 - This practice parameter is for both FDG and amyloid brain PET or PET/computed tomography (CT) for patients with cognitive decline, and has been developed collaboratively by the American College of Radiology (ACR) and the American Society for Neuroradiology (ASNR). It is estimated that the number of people with dementia, 36.5 million worldwide in 2010, will increase to 65.7 million in 2030 and to 115 million in 2050. Four primary neurodegenerative etiologies of dementia have been defined: Alzheimer disease (AD), vascular dementia, frontotemporal dementia (FTD), and dementia with Lewy bodies (DLB). Alzheimer disease is the most common form of dementia, accounting for approximately 60%-80% of all cases. Indications for FDG and amyloid brain PET and qualifications for personnel are discussed in this practice parameter.

AB - This practice parameter is for both FDG and amyloid brain PET or PET/computed tomography (CT) for patients with cognitive decline, and has been developed collaboratively by the American College of Radiology (ACR) and the American Society for Neuroradiology (ASNR). It is estimated that the number of people with dementia, 36.5 million worldwide in 2010, will increase to 65.7 million in 2030 and to 115 million in 2050. Four primary neurodegenerative etiologies of dementia have been defined: Alzheimer disease (AD), vascular dementia, frontotemporal dementia (FTD), and dementia with Lewy bodies (DLB). Alzheimer disease is the most common form of dementia, accounting for approximately 60%-80% of all cases. Indications for FDG and amyloid brain PET and qualifications for personnel are discussed in this practice parameter.

KW - Alzheimer disease

KW - amyloid PET

KW - Brain imaging

KW - Brain PET/CT

KW - dementia

KW - frontotemporal dementia

KW - FTD

KW - memory

KW - PET/CT

KW - vascular dementia

UR - http://www.scopus.com/inward/record.url?scp=84955203607&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84955203607&partnerID=8YFLogxK

U2 - 10.1097/RLU.0000000000001037

DO - 10.1097/RLU.0000000000001037

M3 - Article

C2 - 26646994

AN - SCOPUS:84955203607

VL - 41

SP - 118

EP - 125

JO - Clinical Nuclear Medicine

JF - Clinical Nuclear Medicine

SN - 0363-9762

IS - 2

ER -